These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14677202)

  • 41. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.
    Chandran V; Schentag CT; Gladman DD
    Arthritis Rheum; 2007 Dec; 57(8):1560-3. PubMed ID: 18050230
    [No Abstract]   [Full Text] [Related]  

  • 42. Sensorineural hearing loss in a patient with HLA-B27 sclero-uveitis.
    Rao V; Gallagher M; Bhat P; Foster CS
    Br J Ophthalmol; 2008 Mar; 92(3):425. PubMed ID: 17537786
    [No Abstract]   [Full Text] [Related]  

  • 43. A simple and practical agglutination assay for human leucocyte antigen-B27 typing.
    Meyer O; Abdallah Z; Schönemann C; Hugo F; Agaylan A; Kiesewetter H; Salama A
    Vox Sang; 2006 Jul; 91(1):77-80. PubMed ID: 16756605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
    Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concepts and epidemiology of spondyloarthritis.
    Sieper J; Rudwaleit M; Khan MA; Braun J
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):401-17. PubMed ID: 16777573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psoriatic arthritis.
    Rajendran CP; Ledge SG; Rani KP; Madhavan R
    J Assoc Physicians India; 2003 Nov; 51():1065-8. PubMed ID: 15260390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The distribution of HLA alleles class I and class II among patientes with psoriatic arthritis in Croatia].
    Grubić Z; Perić P; Cecuk-Jelicić E; Zunec R; Curković B; Kerhin-Brkljacić V
    Reumatizam; 2004; 51(1):5-11. PubMed ID: 15554365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
    Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
    Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27.
    Schiellerup P; Krogfelt KA; Locht H
    J Rheumatol; 2008 Mar; 35(3):480-7. PubMed ID: 18203313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of HLA B27 in diagnosis of seronegative spondyloarthropathies.
    Sonkar GK; Usha
    Indian J Pathol Microbiol; 2007 Oct; 50(4):908-13. PubMed ID: 18306603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-C locus alleles distribution in patients from northern Poland with psoriatic arthritis--preliminary report.
    Szczerkowska Dobosz A; Rebała K; Szczerkowska Z; Nedoszytko B
    Int J Immunogenet; 2005 Dec; 32(6):389-91. PubMed ID: 16313304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunological phenotype of skin lymphoid cells in patients with psoriatic arthritis during rehabilitation].
    Badalov NG; Tupitsyn NN; Grigor'eva VD
    Vopr Kurortol Fizioter Lech Fiz Kult; 2003; (5):8-12. PubMed ID: 14650125
    [No Abstract]   [Full Text] [Related]  

  • 55. Osteoarticular involvement of brucellosis and HLA-B27 antigen frequency in Turkish patients.
    Ertem GT; Tanyel E; Tulek N; Ulkar GB; Doganci L
    Diagn Microbiol Infect Dis; 2004 Apr; 48(4):243-5. PubMed ID: 15062915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis.
    Alenius GM; Friberg C; Nilsson S; Wahlström J; Dahlqvist SR; Samuelsson L
    J Rheumatol; 2004 Nov; 31(11):2230-5. PubMed ID: 15517637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunopathology of psoriasis and psoriatic arthritis.
    Veale DJ; Ritchlin C; FitzGerald O
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii26-9. PubMed ID: 15708930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferative vitreoretinopathy developed in HLA-B27-associated uveitis.
    Kodama M; Numaga J; Kaburaki T; Imamura A; Sakurai M; Fujino Y; Kawashima H
    Eye (Lond); 2003 Aug; 17(6):782-4. PubMed ID: 12928698
    [No Abstract]   [Full Text] [Related]  

  • 59. HLA studies in psoriatic arthritis: current situation and future needs.
    Gladman DD; Farewell VT
    J Rheumatol; 2003 Jan; 30(1):4-6. PubMed ID: 12508382
    [No Abstract]   [Full Text] [Related]  

  • 60. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.